Taking stem cell therapies to patients: the role of commercialisation

See on Scoop.itMedically speaking

A new treatment needs a licenceUnder European law, anything that treats or diagnoses a disease is classed as a Medicinal Product and must have a government licence before it can be offered to patients (with a few specific exceptions for hospitals).

See on www.eurostemcell.org

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s